NO953270D0 - Fibrinogenreceptorantagonister - Google Patents
FibrinogenreceptorantagonisterInfo
- Publication number
- NO953270D0 NO953270D0 NO953270A NO953270A NO953270D0 NO 953270 D0 NO953270 D0 NO 953270D0 NO 953270 A NO953270 A NO 953270A NO 953270 A NO953270 A NO 953270A NO 953270 D0 NO953270 D0 NO 953270D0
- Authority
- NO
- Norway
- Prior art keywords
- fibrinogenreceptorantagonister
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2051793A | 1993-02-22 | 1993-02-22 | |
| PCT/US1994/001881 WO1994018981A1 (en) | 1993-02-22 | 1994-02-22 | Fibrinogen receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO953270D0 true NO953270D0 (en) | 1995-08-21 |
| NO953270L NO953270L (en) | 1995-10-19 |
Family
ID=21799049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953270A NO953270L (en) | 1993-02-22 | 1995-08-21 | Fibrinogenreceptorantagonister |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0684823A4 (en) |
| JP (1) | JP3173792B2 (en) |
| KR (1) | KR960700722A (en) |
| CN (1) | CN1118139A (en) |
| AU (1) | AU680240B2 (en) |
| BG (1) | BG99863A (en) |
| CA (1) | CA2155123A1 (en) |
| CZ (1) | CZ210895A3 (en) |
| FI (1) | FI953916A0 (en) |
| HU (1) | HUT71796A (en) |
| NO (1) | NO953270L (en) |
| NZ (1) | NZ262664A (en) |
| PL (1) | PL310386A1 (en) |
| SK (1) | SK102495A3 (en) |
| WO (1) | WO1994018981A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5494921A (en) * | 1994-09-16 | 1996-02-27 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
| CN1085980C (en) * | 1995-08-30 | 2002-06-05 | G·D·瑟尔公司 | meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| US6100423A (en) * | 1995-08-30 | 2000-08-08 | G. D. Searle & Co. | Amino benzenepropanoic acid compounds and derivatives thereof |
| CA2233204A1 (en) | 1995-09-29 | 1997-04-03 | Joseph A. Jakubowski | Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| JP2000501105A (en) * | 1995-12-22 | 2000-02-02 | デュポン ファーマシューティカルズ カンパニー | Novel integrin receptor antagonist |
| WO1997035579A1 (en) * | 1996-03-27 | 1997-10-02 | Merck & Co., Inc. | A method for inhibiting clot formation |
| ES2271971T3 (en) * | 1996-07-25 | 2007-04-16 | Biogen Idec Ma Inc. | INHIBITORS OF CELL ADHESION. |
| US5900414A (en) * | 1996-08-29 | 1999-05-04 | Merck & Co., Inc. | Methods for administering integrin receptor antagonists |
| DE19653647A1 (en) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin receptor antagonists, their preparation and their use |
| CA2279927A1 (en) * | 1997-02-06 | 1998-08-13 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
| US6214834B1 (en) | 1997-03-28 | 2001-04-10 | Dupont Pharmaceuticals Company | Integrin inhibitor prodrugs |
| US6303625B1 (en) * | 1998-07-27 | 2001-10-16 | Ortho-Mcneil Pharmaceutical, Inc. | Triazolopyridines for the treatment of thrombosis disorders |
| AU773227B2 (en) * | 1999-07-28 | 2004-05-20 | Aventis Pharmaceuticals Inc. | Substituted oxoazaheterocyclyl compounds |
| CA2510298A1 (en) * | 2002-12-20 | 2004-07-15 | Pharmacia Corporation | Acyclic pyrazole compounds |
| AU2007272009A1 (en) * | 2006-07-12 | 2008-01-17 | Syngenta Limited | Triazolopyridine derivatives as herbicides |
| KR20100132999A (en) * | 2008-04-04 | 2010-12-20 | 길리애드 사이언시즈, 인코포레이티드 | Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors |
| WO2010096722A1 (en) * | 2009-02-20 | 2010-08-26 | Takeda Pharmaceutical Company Limited | 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| GB8913011D0 (en) * | 1989-06-06 | 1989-07-26 | Wellcome Found | Anticonvulsant pyrazines |
| US5166154A (en) * | 1989-10-17 | 1992-11-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Imidazo[1,2-a]piperazines |
| US5278161A (en) * | 1990-06-28 | 1994-01-11 | Hoffmann-La Roche Inc. | Amino acid derivatives useful as renin inhibitors |
-
1994
- 1994-02-22 NZ NZ262664A patent/NZ262664A/en unknown
- 1994-02-22 JP JP51922094A patent/JP3173792B2/en not_active Expired - Fee Related
- 1994-02-22 PL PL94310386A patent/PL310386A1/en unknown
- 1994-02-22 EP EP94909745A patent/EP0684823A4/en not_active Withdrawn
- 1994-02-22 HU HU9502028A patent/HUT71796A/en unknown
- 1994-02-22 WO PCT/US1994/001881 patent/WO1994018981A1/en not_active Application Discontinuation
- 1994-02-22 CA CA002155123A patent/CA2155123A1/en not_active Abandoned
- 1994-02-22 AU AU62465/94A patent/AU680240B2/en not_active Ceased
- 1994-02-22 CN CN94191248A patent/CN1118139A/en active Pending
- 1994-02-22 SK SK1024-95A patent/SK102495A3/en unknown
- 1994-02-22 CZ CZ952108A patent/CZ210895A3/en unknown
-
1995
- 1995-08-15 BG BG99863A patent/BG99863A/en unknown
- 1995-08-21 FI FI953916A patent/FI953916A0/en not_active Application Discontinuation
- 1995-08-21 NO NO953270A patent/NO953270L/en unknown
- 1995-08-21 KR KR1019950703563A patent/KR960700722A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL310386A1 (en) | 1995-12-11 |
| NZ262664A (en) | 1997-04-24 |
| JPH08507072A (en) | 1996-07-30 |
| CZ210895A3 (en) | 1996-02-14 |
| JP3173792B2 (en) | 2001-06-04 |
| BG99863A (en) | 1996-02-29 |
| EP0684823A4 (en) | 1997-07-09 |
| KR960700722A (en) | 1996-02-24 |
| AU680240B2 (en) | 1997-07-24 |
| HUT71796A (en) | 1996-02-28 |
| FI953916A (en) | 1995-08-21 |
| FI953916A0 (en) | 1995-08-21 |
| AU6246594A (en) | 1994-09-14 |
| CN1118139A (en) | 1996-03-06 |
| NO953270L (en) | 1995-10-19 |
| CA2155123A1 (en) | 1994-09-01 |
| EP0684823A1 (en) | 1995-12-06 |
| WO1994018981A1 (en) | 1994-09-01 |
| HU9502028D0 (en) | 1995-09-28 |
| SK102495A3 (en) | 1997-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69407573D1 (en) | FLUORSILOXANHYDROGELE | |
| DE69411848T2 (en) | Furanylinsecticides | |
| DE69421035D1 (en) | RINGOSCILLATOR | |
| BR9405832A (en) | Imidazoazins | |
| DE69413933T2 (en) | ANTITUSSIVA | |
| DE69331809D1 (en) | VISKOSIMETER | |
| NO953270D0 (en) | Fibrinogenreceptorantagonister | |
| ATA146094A (en) | WINDSIGHTER | |
| DE69410500D1 (en) | Multi-turntable | |
| DE59407673D1 (en) | 2-oximino-2-phenyl-acetamide | |
| DE69421322T2 (en) | Cyclopropyl-substituted spiro-photochromic | |
| DE59309062D1 (en) | Mixer-dryer | |
| DE59410180D1 (en) | 4-Cyanophenyliminoheterocyclen | |
| ATA194593A (en) | SPORTSHOE | |
| ATA179094A (en) | CHAINLOCK | |
| FI932036A0 (en) | fartyg | |
| DE69330490T2 (en) | Ladungsabtastschaltung | |
| DE59410298D1 (en) | Hefeerntetank | |
| FI909U1 (en) | Torvkvarn | |
| FI906U1 (en) | Mjaerde Foer kraeftor | |
| DE69409638T2 (en) | 2-METHYLBUTOXYETHOXYETHANOL | |
| DE69420364D1 (en) | Liponucleotides | |
| BR9301265A (en) | Aplicatex | |
| BR9303301A (en) | Game-ecology | |
| FIU930098U0 (en) | Ryggbehandlingsanordning |